title: Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: potential TB vaccine candidate antigen.
abstract: BACKGROUND
  To date, the function of many hypothetical membrane proteins of Mycobacterium tuberculosis is still unknown and their involvement in pathogen-host interactions has not been yet clearly defined. In this study, the biological activity of peptides derived from the hypothetical membrane protein Rv0679c of M. tuberculosis and their involvement in pathogen-host interactions was assessed. Transcription of the Rv0679c gene was studied in 26 Mycobacterium spp. Strains. Antibodies raised against putative B-cell epitopes of Rv0679c were used in Western blot and immunoelectron microscopy assays. Synthetic peptides spanning the entire length of the protein were tested for their ability to bind to A549 and U937 cells. High-activity binding peptides (HABPs) identified in Rv0679c were tested for their ability to inhibit mycobacterial invasion into cells.
  
  
  RESULTS
  The gene encoding Rv0679c was detected in all strains of the M. tuberculosis complex (MTC), but was only transcribed in M. tuberculosis H37Rv, M. tuberculosis H37Ra and M. africanum. Anti-Rv0679c antibodies specifically recognized the protein in M. tuberculosis H37Rv sonicate and showed its localization on mycobacterial surface. Four HABPs inhibited invasion of M. tuberculosis to target cells by up to 75%.
  
  
  CONCLUSIONS
  The results indicate that Rv0679c HABPs and in particular HABP 30979 could be playing an important role during M. tuberculosis invasion of host cells, and therefore could be interesting research targets for studies aimed at developing strategies to control tuberculosis.
authors.affiliation: Fundación Instituto de Inmunología de Colombia, Carrera 50 No, 26-20, Bogotá, Colombia.
authors.forename: Diana P
authors.initials: DP
authors.lastname: Cifuentes
authors.forename: Marisol
authors.initials: M
authors.lastname: Ocampo
authors.forename: Hernando
authors.initials: H
authors.lastname: Curtidor
authors.forename: Magnolia
authors.initials: M
authors.lastname: Vanegas
authors.forename: Martha
authors.initials: M
authors.lastname: Forero
authors.forename: Manuel E
authors.initials: ME
authors.lastname: Patarroyo
authors.forename: Manuel A
authors.initials: MA
authors.lastname: Patarroyo
mesh_terms: D000907:Antibodies, Bacterial / Q000302:isolation & purification; D000942:Antigens, Bacterial / Q000276:immunology / Q000502:physiology*; D001426:Bacterial Proteins / Q000276:immunology / Q000502:physiology*; D015153:Blotting, Western; D002460:Cell Line; D004847:Epithelial Cells / Q000382:microbiology; D018985:Epitopes, B-Lymphocyte / Q000276:immunology; D020869:Gene Expression Profiling; D054884:Host-Pathogen Interactions; D006801:Humans; D016253:Microscopy, Immunoelectron; D009000:Monocytes / Q000382:microbiology; D009169:Mycobacterium tuberculosis / Q000472:pathogenicity*; D011485:Protein Binding; D032581:Tuberculosis Vaccines / Q000276:immunology; D037521:Virulence Factors / Q000276:immunology / Q000502:physiology*
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D018985:Epitopes, B-Lymphocyte; D032581:Tuberculosis Vaccines; D037521:Virulence Factors
references.citation: Expert Rev Vaccines. 2004 Feb;3(1):23-34
references.pmid: 14761241
references.citation: FEMS Microbiol Rev. 2004 Nov;28(5):645-59
references.pmid: 15539077
references.citation: Infect Immun. 2000 Jun;68(6):3314-21
references.pmid: 10816479
references.citation: Infect Immun. 1996 Apr;64(4):1400-6
references.pmid: 8606107
references.citation: Mol Microbiol. 2004 Jul;53(2):391-403
references.pmid: 15228522
references.citation: J Clin Microbiol. 1991 Oct;29(10):2163-8
references.pmid: 1939567
references.citation: Protein Sci. 2005 Nov;14(11):2767-80
references.pmid: 16199660
references.citation: Infect Immun. 1988 Dec;56(12):3310-2
references.pmid: 3141288
references.citation: FEBS J. 2007 Dec;274(24):6352-64
references.pmid: 18005255
references.citation: Int J Cancer. 2003 Nov 10;107(3):416-24
references.pmid: 14506742
references.citation: Infect Immun. 1998 Apr;66(4):1277-81
references.pmid: 9529042
references.citation: Clin Infect Dis. 2003 Nov 1;37(9):1226-33
references.pmid: 14557968
references.citation: J Bacteriol. 2009 Apr;191(8):2721-7
references.pmid: 19233923
references.citation: Protein Sci. 2005 Feb;14(2):504-13
references.pmid: 15659379
references.citation: Infect Immun. 1991 Apr;59(4):1558-63
references.pmid: 1900811
references.citation: Curr Opin Infect Dis. 2008 Jun;21(3):279-86
references.pmid: 18448973
references.citation: Biochem Biophys Res Commun. 2005 Jul 8;332(3):771-81
references.pmid: 15907793
references.citation: Protein Sci. 1999 Feb;8(2):370-80
references.pmid: 10048330
references.citation: Eur J Immunol. 2009 Mar;39(3):676-86
references.pmid: 19283721
references.citation: Int J Tuberc Lung Dis. 2006 Oct;10(10):1068-79
references.pmid: 17044198
references.citation: Vaccine. 2002 Jan 31;20(9-10):1331-9
references.pmid: 11818151
references.citation: Microbiology (Reading). 2007 Mar;153(Pt 3):652-658
references.pmid: 17322184
references.citation: Front Biosci. 2008 Jan 01;13:650-6
references.pmid: 17981577
references.citation: Eur J Immunol. 2000 Jun;30(6):1724-32
references.pmid: 10898510
references.citation: Wien Klin Wochenschr. 2003 Oct 31;115(19-20):685-97
references.pmid: 14650943
references.citation: Vaccine. 2000 Nov 8;19(6):601-12
references.pmid: 11090710
references.citation: Protein Sci. 2005 Sep;14(9):2236-45
references.pmid: 16131654
references.citation: Chemotherapy. 1999;45 Suppl 2:34-40
references.pmid: 10449896
references.citation: Protein Sci. 2008 Feb;17(2):342-51
references.pmid: 18096644
references.citation: Int J Pept Protein Res. 1983 Jan;21(1):57-65
references.pmid: 6826283
references.citation: Proc Natl Acad Sci U S A. 1985 Aug;82(15):5131-5
references.pmid: 2410914
references.citation: Clin Diagn Lab Immunol. 2001 May;8(3):571-8
references.pmid: 11329460
references.citation: Int J Lepr Other Mycobact Dis. 1986 Sep;54(3):409-15
references.pmid: 2427627
references.citation: Clin Exp Immunol. 2000 Feb;119(2):270-9
references.pmid: 10632662
references.citation: Vaccine. 2008 Nov 11;26(48):6053-63
references.pmid: 18822333
references.citation: Nature. 1998 Jun 11;393(6685):537-44
references.pmid: 9634230
references.citation: Protein Sci. 2005 Feb;14(2):464-73
references.pmid: 15659376
references.citation: Microb Pathog. 2003 Aug;35(2):49-55
references.pmid: 12901843
references.citation: J Clin Microbiol. 2000 Aug;38(8):2966-71
references.pmid: 10921960
references.citation: Infect Immun. 1991 Jun;59(6):1905-10
references.pmid: 1903768
references.citation: Biochem Biophys Res Commun. 2008 Aug 8;372(4):935-40
references.pmid: 18539140
references.citation: Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1530-4
references.pmid: 7878014
references.citation: Biochem Biophys Res Commun. 2004 Jun 18;319(1):221-9
references.pmid: 15158465
references.citation: Arch Microbiol. 2007 Apr;187(4):297-311
references.pmid: 17252234
references.citation: J Med Microbiol. 2007 Sep;56(Pt 9):1145-1151
references.pmid: 17761475
references.citation: Tuberculosis (Edinb). 2009 Jan;89(1):54-61
references.pmid: 19056317